Guangzhou Wondfo Biotech Co Ltd
SZSE:300482

Watchlist Manager
Guangzhou Wondfo Biotech Co Ltd Logo
Guangzhou Wondfo Biotech Co Ltd
SZSE:300482
Watchlist
Price: 24.29 CNY -6.22% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Guangzhou Wondfo Biotech Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Guangzhou Wondfo Biotech Co Ltd

Current Assets 3.7B
Cash & Short-Term Investments 2.3B
Receivables 930.9m
Other Current Assets 434.6m
Non-Current Assets 3B
Long-Term Investments 1.1B
PP&E 1.4B
Intangibles 372.5m
Other Non-Current Assets 104.4m
Current Liabilities 489.7m
Accounts Payable 196.4m
Accrued Liabilities 140.1m
Short-Term Debt 13.7m
Other Current Liabilities 139.5m
Non-Current Liabilities 797.3m
Long-Term Debt 600m
Other Non-Current Liabilities 197.3m

Balance Sheet
Guangzhou Wondfo Biotech Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
152
476
577
343
1 091
881
1 407
995
1 160
833
Cash
0
0
0
1
0
2
0
995
1 160
833
Cash Equivalents
152
476
576
343
1 090
880
1 407
0
0
0
Short-Term Investments
0
0
0
39
77
100
103
573
1 138
1 345
Total Receivables
27
40
65
285
411
494
345
570
621
678
Accounts Receivables
23
37
58
246
358
419
269
498
540
598
Other Receivables
3
3
7
39
53
76
76
72
81
80
Inventory
51
49
79
131
166
224
377
386
400
351
Other Current Assets
3
4
6
160
29
43
39
61
30
25
Total Current Assets
234
569
726
957
1 774
1 741
2 270
2 586
3 350
3 233
PP&E Net
147
151
224
254
397
506
677
906
1 189
1 353
PP&E Gross
147
151
224
254
397
506
677
906
1 189
1 353
Accumulated Depreciation
46
62
83
132
158
209
258
347
471
567
Intangible Assets
15
16
21
121
125
183
224
262
255
261
Goodwill
0
0
7
155
155
120
48
43
115
111
Long-Term Investments
6
54
6
170
188
320
1 025
971
1 284
709
Other Long-Term Assets
6
8
22
38
54
75
62
88
106
104
Other Assets
0
0
7
155
155
120
48
43
115
111
Total Assets
407
N/A
799
+96%
1 006
+26%
1 695
+69%
2 692
+59%
2 944
+9%
4 306
+46%
4 856
+13%
6 301
+30%
5 772
-8%
Liabilities
Accounts Payable
26
35
51
141
150
157
300
400
320
130
Accrued Liabilities
20
20
25
49
73
131
194
187
238
195
Short-Term Debt
0
0
7
46
51
21
107
29
219
16
Current Portion of Long-Term Debt
0
0
0
0
69
9
9
28
17
19
Other Current Liabilities
34
31
57
146
181
126
184
148
347
124
Total Current Liabilities
81
86
140
380
524
443
793
792
1 141
484
Long-Term Debt
0
0
0
114
0
22
502
521
544
581
Deferred Income Tax
0
0
0
0
3
8
9
30
56
55
Minority Interest
0
0
12
161
217
237
151
151
194
99
Other Liabilities
12
12
11
10
14
11
8
9
23
37
Total Liabilities
94
N/A
98
+5%
163
+67%
666
+308%
757
+14%
721
-5%
1 464
+103%
1 503
+3%
1 957
+30%
1 256
-36%
Equity
Common Stock
66
88
176
178
343
343
343
445
445
445
Retained Earnings
162
234
379
564
776
1 089
1 637
2 101
3 166
3 433
Additional Paid In Capital
86
379
291
350
876
863
866
787
776
766
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
59
8
103
Treasury Stock
0
0
0
64
59
67
128
139
157
132
Other Equity
0
0
3
2
1
4
124
100
108
109
Total Equity
313
N/A
701
+124%
843
+20%
1 029
+22%
1 935
+88%
2 223
+15%
2 842
+28%
3 353
+18%
4 344
+30%
4 516
+4%
Total Liabilities & Equity
407
N/A
799
+96%
1 006
+26%
1 695
+69%
2 692
+59%
2 944
+9%
4 306
+46%
4 856
+13%
6 301
+30%
5 772
-8%
Shares Outstanding
Common Shares Outstanding
309
412
412
412
441
440
440
443
442
442

See Also

Discover More